Iterum TherapeuticsITRMF
13F holders, Q3 2024 (September 30)3holders +2
2new positions
0sold out
$1.09avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings, up 2 from Q2 2024. 2 opened new positions and 0 sold out. The largest holders were Cypress Capital Management LLC (WY) ($72), Blue Bell Private Wealth Management, LLC ($72) and Avior Wealth Management, LLC ($14).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L101
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $86 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 79 shares bought, net +79 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Cypress Capital Management LLC (WY) | 0.00% | New | 66 | $72 |
| Blue Bell Private Wealth Management, LLC | 0.00% | No change | 66 | $72 |
| Avior Wealth Management, LLC | 0.00% | New | 13 | $14 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.